MARK WEISS, M.D.
Ophthalmology Physician in NEW HYDE PARK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARK WEISS, M.D. reported a CMS MIPS final score of 5.6916/100 — below the 83.1 national average — and filed 1,680 Medicare Part D claims in 2023.
- 5.6916/100
- MIPS score · -77 vs avg
- 2K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARK WEISS, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
6 2nd percentile higher than 2% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MARK WEISS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MARK WEISS, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Ophthalmology Physician compares to other specialties among New York providers
Ophthalmology Physician share within New York
Ophthalmology Physician is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MARK WEISS, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 5.6916/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) — 5.6916/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Ophthalmology Physician US NPIs
5.6916/100 MIPS final score — 77.4 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 0. Cost dim: 18.972.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARK WEISS, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 2001 MARCUS AVE, NEW HYDE PARK, NY, 11042, with a listed phone of (516) 775-3937. NPI 1114079746 was issued on 01/16/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WEISS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,680 prescription claims written by this provider, covering 386 Medicare beneficiaries and totaling roughly $449K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 5.6916/100 for the 2023 performance year (Quality 0, Cost 18.972), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1114079746 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 01/16/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARK WEISS, M.D.'s current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MARK WEISS, M.D.. To verify MARK WEISS, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,384
- Total Day Supply
- 96,805
- Generic Drug Cost
- $68K
- Antibiotic Claims
- 15
Patient Demographics
- Average Patient Age
- 76.7 years
- Avg HCC Risk Score
- 1.02
- Gender Split
- 65% female / 35% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARK WEISS, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
309 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
165 claims
- Lumigan 101
Lumigan
101 claims
- Moxifloxacin 99
Moxifloxacin
99 claims
- Timolol Maleate 92
Timolol Maleate
92 claims
- Prednisolone Acetate 88
Prednisolone Acetate
88 claims
- Restasis 66
Restasis
66 claims
- Prolensa 64
Prolensa
64 claims
| Drug | Claims |
|---|---|
| Latanoprost | 309 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 165 |
| Lumigan Bimatoprost | 101 |
| Moxifloxacin Moxifloxacin Hcl | 99 |
| Timolol Maleate | 92 |
| Prednisolone Acetate | 88 |
| Restasis Cyclosporine | 66 |
| Prolensa Bromfenac Sodium | 64 |
| Erythromycin Erythromycin Base | 54 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 44 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How MARK WEISS, M.D. fits within the Ophthalmology Physician landscape nationally.
MARK WEISS, M.D.'s 1,680 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as WEISS.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is MARK WEISS, M.D.'s specialty? ▼
How much does MARK WEISS, M.D. prescribe under Medicare Part D? ▼
What is MARK WEISS, M.D.'s Medicare quality score? ▼
Where is MARK WEISS, M.D. located? ▼
What is MARK WEISS, M.D.'s NPI number? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does MARK WEISS, M.D. prescribe most often? ▼
Does MARK WEISS, M.D. accept Medicare? ▼
How can I verify MARK WEISS, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology